title: Insights into the posttranslational structural heterogeneity of thyroglobulin and its role in the development, diagnosis, and management of benign and malignant thyroid diseases.
abstract: Thyroglobulin (Tg) is the major glycoprotein produced by the thyroid gland, where it serves as a template for thyroid hormone synthesis and as an intraglandular store of iodine. Measurement of Tg levels in serum is of great practical importance in the follow-up of differentiated thyroid carcinoma (DTC), a setting in which elevated levels after total thyroidectomy are indicative of residual or recurrent disease. The most recent methods for serum Tg measurement are monoclonal antibody-based and are highly sensitive. However, major challenges remain regarding the interpretation of the results obtained with these immunometric methods, particularly in patients with endogenous antithyroglobulin antibodies or in the presence of heterophile antibodies, which may produce falsely low or high Tg values, respectively. The increased prevalence of antithyroglobulin antibodies in patients with DTC, as compared with the general population, raises the very pertinent possibility that tumor Tg may be more immunogenic. This inference makes sense, as the tumor microenvironment (tumor cells plus normal host cells) is characterized by several changes that could induce posttranslational modification of many proteins, including Tg. Attempts to understand the structure of Tg have been made for several decades, but findings have generally been incomplete due to technical hindrances to analysis of such a large protein (660 kDa). This review article will explore the complex structure of Tg and the potential role of its marked heterogeneity in our understanding of normal thyroid biology and neoplastic processes.
authors.affiliation: Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
authors.forename: Ana Carolina W
authors.initials: AC
authors.lastname: Xavier
authors.affiliation: Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
authors.forename: Rui M B
authors.initials: RM
authors.lastname: Maciel
authors.affiliation: Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
authors.forename: José Gilberto H
authors.initials: JG
authors.lastname: Vieira
authors.affiliation: Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
authors.forename: Magnus R
authors.initials: MR
authors.lastname: Dias-da-Silva
authors.affiliation: Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
authors.forename: João R M
authors.initials: JR
authors.lastname: Martins
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood; D006031:Glycosylation; D054879:Halogenation; D006801:Humans; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D013954:Thyroglobulin / Q000737:chemistry / Q000378:metabolism*; D013959:Thyroid Diseases / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D013963:Thyroid Hormones / Q000096:biosynthesis
chemical_list: D014408:Biomarkers, Tumor; D013963:Thyroid Hormones; D013954:Thyroglobulin